Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Cited by (1,005)

Items 201–300 of 1,005

  1. Multistage Delivery Nanoparticle Facilitates Efficient CRISPR/dCas9 Activation and Tumor Growth Suppression In Vivo
    Qi Liu, Kai Zhao, Chun Wang, Zhanzhan Zhang, Chunxiong Zheng, Yu Zhao, Yadan Zheng, Chaoyong Liu, Yingli An, Linqi Shi et al. · 2018 · Advanced Science
  2. On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals
    Francisco J. M. Mojica, Lluís Montoliu · 2016 · Trends in Microbiology
  3. A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9
    Basudeb Maji, Soumyashree A. Gangopadhyay, Miseon Lee, Meng‐Chao Shi, Peng Wu, Robert Heler, Beverly Y. Mok, Donghyun Lim, Sachini U. Siriwardena, Bishwajit Paul et al. · 2019 · Cell
  4. Spatiotemporal control of CRISPR/Cas9 gene editing
    Chenya Zhuo, Jiabin Zhang, Jung‐Hwan Lee, Ju Jiao, Du Cheng, Li Liu, Hae‐Won Kim, Yu Tao, Mingqiang Li · 2021 · Signal Transduction and Targeted Therapy
  5. Rational designs of in vivo CRISPR-Cas delivery systems
    Cong‐Fei Xu, Guojun Chen, Ying‐Li Luo, Yue Zhang, Gui Zhao, Zi-Dong Lu, Anna Czarna, Zhen Gu, Jun Wang · 2019 · Advanced Drug Delivery Reviews
  6. Human pluripotent reprogramming with CRISPR activators
    Weltner, Jere, Balboa, Diego, Katayama, Shintaro, Bespalov, Maxim, Krjutškov, Kaarel, Jouhilahti, Eeva-Mari, Trokovic, Ras, Kere, Juha, Otonkoski, Timo · 2018 · Nature Communications
  7. Self-Assembling Nucleic Acid Nanostructures Functionalized with Aptamers
    Abhichart Krissanaprasit, Carson M. Key, Sahil Pontula, Thomas H. LaBean · 2021 · Chemical Reviews
  8. lncRNAs in development and disease: from functions to mechanisms
    M. Joaquina Delàs, Gregory J. Hannon · 2017 · Open Biology
  9. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
    Qiaoqiao Xiao, Deyin Guo, Shuliang Chen · 2019 · Frontiers in Cellular and Infection Microbiology
  10. Development of CRISPR-Cas systems for genome editing and beyond
    F. Zhang · 2019 · Quarterly Reviews of Biophysics
  11. Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9
    Ceasar, S. Antony, Rajan, Vinothkumar, Prykhozhij, Sergey V., Berman, Jason N., Ignacimuthu, S. · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  12. Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy
    Victoria H. Wu, Huwate Yeerna, Nijiro Nohata, Joshua Chiou, Olivier Harismendy, Francesco Raimondi, Asuka Inoue, Robert B. Russell, Pablo Tamayo, Jorge Silvio Gutkind · 2019 · Journal of Biological Chemistry
  13. RNA-dependent chromatin targeting of TET2 for endogenous retrovirus control in pluripotent stem cells
    Diana Guallar, Xianju Bi, José Ángel Pardavila, Xin Huang, Carmen Sáenz, Xianle Shi, Hongwei Zhou, Francesco Faiola, Junjun Ding, Phensinee Haruehanroengra et al. · 2018 · Nature Genetics
  14. CRISPR/Cas9 Immune System as a Tool for Genome Engineering
    Magdalena Hryhorowicz, Daniel Lipiński, Joanna Zeyland, Ryszard Słomski · 2016 · Archivum Immunologiae et Therapiae Experimentalis
  15. CRISPR–Cas: a tool for cancer research and therapeutics
    Hao Yin, Wen Xue, Daniel G. Anderson · 2019 · Nature Reviews Clinical Oncology
  16. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement
    Chao Li, Eleanor J. Brant, Hikmet Budak, Baohong Zhang · 2021 · Journal of Zhejiang University SCIENCE B
  17. Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation
    Diego Balboa, Jere Weltner, Solja Eurola, Ras Trokovic, Kirmo Wartiovaara, Timo Otonkoski · 2015 · Stem Cell Reports
  18. Multidimensional chemical control of CRISPR–Cas9
    Basudeb Maji, Christopher L Moore, Bernd Zetsche, Sara E. Volz, Feng Zhang, Matthew D. Shoulders, Amit Choudhary · 2016 · Nature Chemical Biology
  19. RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors
    Pratiksha I. Thakore, Jennifer B. Kwon, Christopher E. Nelson, Douglas C. Rouse, Matthew P. Gemberling, Matthew L. Oliver, Charles A. Gersbach · 2018 · Nature Communications
  20. Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
    Chenxi Tian, Daniel Öhlund, Steffen Rickelt, Tommy Lidström, Ying Huang, Liangliang Hao, Renee Tan Zhao, Oskar Franklin, Sangeeta N. Bhatia, David A. Tuveson et al. · 2020 · Cancer Research
  21. Advances in CRISPR therapeutics
    Michael Chavez, Xinyi Chen, Paul B. Finn, Lei S. Qi · 2022 · Nature Reviews Nephrology
  22. Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing
    Carlson-Stevermer, Jared, Abdeen, Amr A., Kohlenberg, Lucille, Goedland, Madelyn, Molugu, Kaivalya, Lou, Meng, Saha, Krishanu · 2017 · Nature Communications
  23. How the epigenome integrates information and reshapes the synapse
    Rianne R. Campbell, Marcelo A. Wood · 2019 · Nature reviews. Neuroscience
  24. EGRINs (Environmental Gene Regulatory Influence Networks) in Rice That Function in the Response to Water Deficit, High Temperature, and Agricultural Environments
    Olivia Wilkins, Christoph Hafemeister, Anne Plessis, Meisha Holloway‐Phillips, Gina M. Pham, Adrienne B. Nicotra, Glenn B. Gregorio, S. V. Krishna Jagadish, Endang M. Septiningsih, Richard Bonneau et al. · 2016 · The Plant Cell
  25. CRISPR–Cas9-based photoactivatable transcription systems to induce neuronal differentiation
    Yuta Nihongaki, Yuichi Furuhata, Takahiro Otabe, Saki Hasegawa, Keitaro Yoshimoto, Moritoshi Sato · 2017 · Nature Methods
  26. Systematic identification of silencers in human cells
    Baoxu Pang, Michael P. Snyder · 2020 · Nature Genetics
  27. Genome editing of crops: A renewed opportunity for food security
    Fawzy Georges, Heather Ray · 2017 · GM crops & food
  28. Emerging roles of long non-coding RNAs in plant response to biotic and abiotic stresses
    Naghmeh Nejat, Nitin L. Mantri · 2017 · Critical Reviews in Biotechnology
  29. Current and Future Treatment Strategies for Rhabdomyosarcoma
    Celine Y. Chen, Heathcliff Dorado García, Monika Scheer, Anton George Henssen · 2019 · Frontiers in Oncology
  30. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
    Henriette O’Geen, Sofie L. Bates, Sakereh Carter, Karly Nisson, Julian A. N. M. Halmai, Kyle D. Fink, Suhn K. Rhie, Peggy Farnham, David Jay Segal · 2019 · Epigenetics & Chromatin
  31. CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency
    Peng Liu, Meng Chen, Yanxia Liu, Lei S. Qi, Sheng Ding · 2018 · Cell stem cell
  32. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering
    Suhyung Cho, Jongoh Shin, Byung‐Kwan Cho · 2018 · International Journal of Molecular Sciences
  33. A split prime editor with untethered reverse transcriptase and circular RNA template
    Bin Liu, Xiaolong Dong, Haoyang Cheng, Chunwei Zheng, Zexiang Chen, Tomás Rodríguez, Shun‐Qing Liang, Wen Xue, Erik J. Sontheimer · 2022 · Nature Biotechnology
  34. Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
    Roman Maresch, Sebastian Mueller, Christian Veltkamp, Rupert Öllinger, Mathias Friedrich, Irina Heid, Katja Steiger, Julia Weber, Thomas Engleitner, Maxim Barenboim et al. · 2016 · Nature Communications
  35. Zebrafish Genome Engineering Using the CRISPR–Cas9 System
    Mingyu Li, Liyuan Zhao, Patrick Page-McCaw, Wenbiao Chen · 2016 · Trends in Genetics
  36. Multi-functional genome-wide CRISPR system for high throughput genotype–phenotype mapping
    Jiazhang Lian, J. Carl Schultz, Mingfeng Cao, Mohammad HamediRad, Huimin Zhao · 2019 · Nature Communications
  37. High-Throughput Discovery and Characterization of Human Transcriptional Effectors
    Josh Tycko, Nicole V. DelRosso, Gaelen T. Hess, Aradhana, Abhimanyu Banerjee, Adi Xiyal Mukund, Mike V. Van, Braeden K. Ego, David Yao, Kaitlyn Spees et al. · 2020 · Cell
  38. Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference
    Rodolphe Barrangou, Amanda Birmingham, Stefan Wiemann, Roderick L. Beijersbergen, Veit Hornung, Anja van Brabant Smith · 2015 · Nucleic Acids Research
  39. Casilio: a versatile CRISPR-Cas9-Pumilio hybrid for gene regulation and genomic labeling
    Albert W. Cheng, Nathaniel Jillette, Phoebe L. Lee, Dylan M. Plaskon, Yasuhiro Fujiwara, Wenbo Wang, Aziz Taghbalout, Haoyi Wang · 2016 · Cell Research
  40. Engineering microbial hosts for production of bacterial natural products
    Mingzi M. Zhang, Yajie Wang, Ee Lui Ang, Huimin Zhao · 2016 · Natural Product Reports
  41. Genetic interaction mapping in mammalian cells using CRISPR interference
    Dan Du, Assen Roguev, David Ezra Gordon, Meng Chen, Sihan Chen, Michael Shales, John Paul Shen, Trey Ideker, Prashant Mali, Lei S. Qi et al. · 2017 · Nature Methods
  42. CRISPR-based functional genomics for neurological disease
    Kampmann, Martin · 2020 · Nature Reviews Neurology
  43. Long-term dual-color tracking of genomic loci by modified sgRNAs of the CRISPR/Cas9 system
    Shipeng Shao, Weiwei Zhang, Huan Hu, Boxin Xue, Jinshan Qin, Chaoying Sun, Yuao Sun, Wensheng Wei, Yujie Sun · 2016 · Nucleic Acids Research
  44. The regulatory network behind MHC class I expression
    Marlieke L.M. Jongsma, Greta Guarda, Robbert M. Spaapen · 2017 · Molecular Immunology
  45. CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs
    Yonggang Zhang, Chaoran Yin, Ting Zhang, Fang Li, Wensheng Yang, Rafal Kaminski, Philip Regis Fagan, Raj Putatunda, Won‐Bin Young, Kamel Khalili et al. · 2015 · Scientific Reports
  46. Epigenetic regulation of the circadian gene Per1 contributes to age-related changes in hippocampal memory
    Janine L. Kwapis, Yasaman Alaghband, Enikö A. Kramár, Alberto J. López, Annie Vogel Ciernia, André O. White, Guanhua Shu, Diane Rhee, Christina M. Michael, Emilie Montellier et al. · 2018 · Nature Communications
  47. Structural basis for the altered PAM specificities of engineered CRISPR-cas9
    Hirano, Seiichi, Nishimasu, Hiroshi, Ishitani, Ryuichiro, Nureki, Osamu · 2016 · Molecular Cell
  48. Rapid and reversible epigenome editing by endogenous chromatin regulators
    Simon M. G. Braun, Jacob G. Kirkland, Emma J. Chory, Dylan Husmann, Joseph P. Calarco, Gerald R. Crabtree · 2017 · Nature Communications
  49. CRISPR interference-based specific and efficient gene inactivation in the brain
    Yi Zheng, Wei Shen, Jian Zhang, Bo Yang, Yaonan Liu, Huihui Qi, Xia Yu, Si‐Yao Lu, Yun Chen, Yuzhou Xu et al. · 2018 · Nature Neuroscience
  50. Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation
    Jiawei Shao, Meiyan Wang, Guiling Yu, Sucheng Zhu, Yuanhuan Yu, Boon Chin Heng, Jiali Wu, Haifeng Ye · 2018 · Proceedings of the National Academy of Sciences
  51. Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges
    David C. Luther, Y.W. Lee, Harini Nagaraj, Federica Scaletti, Vincent M. Rotello · 2018 · Expert Opinion on Drug Delivery
  52. Current status and perspectives of genome editing technology for microalgae
    Jeon, Seungjib, Lim, Jong-Min, Lee, Hyung-Gwan, Shin, Sung-Eun, Kang, Nam Kyu, Park, Youn-Il, Oh, Hee-Mock, Jeong, Won-Joong, Jeong, Byeong-ryool, Chang, Yong Keun · 2017 · Biotechnology for Biofuels
  53. Dual gene activation and knockout screen reveals directional dependencies in genetic networks
    Michael Boettcher, Ruilin Tian, James A Blau, Evan Markegard, Ryan T. Wagner, David Wu, Xiulei Mo, Anne Biton, Noah Zaitlen, Haian Fu et al. · 2018 · Nature Biotechnology
  54. A CRISPR/Cas13a-powered catalytic electrochemical biosensor for successive and highly sensitive RNA diagnostics
    Yan Sheng, Tenghua Zhang, Shihong Zhang, Midori Johnston, Xiaohe Zheng, Yuanyue Shan, Tong Liu, Zena Huang, Feiyang Qian, Zihui Xie et al. · 2021 · Biosensors and Bioelectronics
  55. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML
    Emily Heikamp, Jill A. Henrich, Florian Perner, Eric M. C. Wong, Charlie Hatton, Yanhe Wen, Sonali P. Barwe, Anilkumar Gopalakrishnapillai, Haiming Xu, Hannah J. Uckelmann et al. · 2021 · Blood
  56. Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma
    Derek Lee, Mingjing Xu, David Kung‐Chun Chiu, Robin Kit‐Ho Lai, Aki Pui‐Wah Tse, Lynna Lan Li, Cheuk‐Ting Law, Felice Ho‐Ching Tsang, Larry Lai Wei, Cerise Yuen‐Ki Chan et al. · 2017 · Journal of Clinical Investigation
  57. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice
    Chih‐Hao Wang, Morten Lundh, Accalia Fu, Rókus Kriszt, Tian Lian Huang, Matthew D. Lynes, Luiz Osório Leiria, Farnaz Shamsi, Justin Darcy, Bennett P. Greenwood et al. · 2020 · Science Translational Medicine
  58. A novel fluorescence biosensor based on CRISPR/Cas12a integrated MXenes for detecting Aflatoxin B1
    Zhihui Wu, Da‐Wen Sun, Hongbin Pu, Qingyi Wei · 2022 · Talanta
  59. Rewiring human cellular input–output using modular extracellular sensors
    Kelly A. Schwarz, Nichole M. Daringer, Taylor B. Dolberg, Joshua N. Leonard · 2016 · Nature Chemical Biology
  60. QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis
    Kwontae You, Lingfei Wang, Chih‐Hung Chou, Kai Liu, Toru Nakata, Alok Jaiswal, Junmei Yao, Ariel J. Lefkovith, Abdifatah S. Omar, Jacqueline Perrigoue et al. · 2020 · Science
  61. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
    Wendy Dong, Boris Kantor · 2021 · Viruses
  62. TALENs—an indispensable tool in the era of CRISPR: a mini review
    Anuradha Bhardwaj, Vikrant Nain · 2021 · Journal of Genetic Engineering and Biotechnology
  63. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes
    Feixiong Cheng, Junfei Zhao, Zhongming Zhao · 2015 · Briefings in Bioinformatics
  64. CRISPR-dCas9 and sgRNA scaffolds enable dual-colour live imaging of satellite sequences and repeat-enriched individual loci
    Yi Fu, Pedro P. Rocha, Vincent Mingyi Luo, Ramya Raviram, Yan Deng, Esteban O. Mazzoni, Jane A. Skok · 2016 · Nature Communications
  65. Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements
    Josh Tycko, Michael Wainberg, Georgi K. Marinov, Oana Ursu, Gaelen T. Hess, Braeden K. Ego, Aradhana, Amy Li, Alisa Truong, Alexandro E. Trevino et al. · 2019 · Nature Communications
  66. CRISPR technologies for bacterial systems: Current achievements and future directions
    Kyeong Rok Choi, Sang Yup Lee · 2016 · Biotechnology Advances
  67. Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
    Ilaria Proietti, Nevena Skroza, Nicoletta Bernardini, Ersilia Tolino, Veronica Balduzzi, Anna Marchesiello, Simone Michelini, Salvatore Volpe, Alessandra Mambrin, Giorgio Mangino et al. · 2020 · Cancers
  68. Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases
    George D. Lampe, Rebeca T. King, Tyler S. Halpin-Healy, Sanne E. Klompe, Marcus I. Hogan, Phuc Leo H. Vo, Stephen Tang, Alejandro Chavez, Samuel H. Sternberg · 2023 · Nature Biotechnology
  69. Assembloid CRISPR screens reveal impact of disease genes in human neurodevelopment
    Xiangling Meng, David Yao, Kent Imaizumi, Xiaoyu Chen, Kevin W. Kelley, Noah Reis, Mayuri Vijay Thete, Arpana Arjun McKinney, Shravanti Kulkarni, Georgia Panagiotakos et al. · 2023 · Nature
  70. Improved plant cytosine base editors with high editing activity, purity, and specificity
    Ren, Qiurong, Sretenovic, Simon, Liu, Guanqing, Zhong, Zhaohui, Wang, Jiaheng, Huang, Lan, Tang, Xu, Guo, Yachong, Liu, Li, Wu, Yuechao et al. · 2021 · Plant Biotechnology Journal
  71. DUX-miR-344-ZMYM2-Mediated Activation of MERVL LTRs Induces a Totipotent 2C-like State
    Fan Yang, Xin Huang, Ruge Zang, Jiayu Chen, Miguel Fidalgo, Carlos Sánchez-Priego, Jihong Yang, Alexander Caichen, Fanglin Ma, Todd S. Macfarlan et al. · 2020 · Cell stem cell
  72. G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers
    Nadia Arang, Jorge Silvio Gutkind · 2020 · FEBS Letters
  73. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs
    Antoine Rebendenne, Priyanka Roy, Boris Bonaventure, Ana Luiza Chaves Valadão, Lowiese M. B. Desmarets, Mary Arnaud‐Arnould, Yves Rouillé, Marine Tauziet, Donatella Giovannini, Jawida Touhami et al. · 2022 · Nature Genetics
  74. CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
    Wei-Jing Dai, Liyao Zhu, Zhongyi Yan, Yong Xu, Qilong Wang, Xiaojie Lu · 2016 · Molecular Therapy — Nucleic Acids
  75. Editing the Epigenome: Reshaping the Genomic Landscape
    Liad Holtzman, Charles A. Gersbach · 2018 · Annual Review of Genomics and Human Genetics
  76. Delivery of CRISPR/Cas9 for therapeutic genome editing
    Xu, Xiaojie, Wan, Tao, Xin, Huhu, Li, Da, Pan, Hongming, Wu, Jun, Ping, Yuan · 2019 · The Journal of Gene Medicine
  77. Opportunities and challenges in modeling human brain disorders in transgenic primates
    Charles G.B. Jennings, Rogier Landman, Yang Zhou, Jitendra Sharma, Julia B. Hyman, J. Anthony Movshon, Zilong Qiu, Angela Roberts, Anna Wang Roe, Xiaoqin Wang et al. · 2016 · Nature Neuroscience
  78. Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection
    Scott B. Biering, Sylvia A. Sarnik, Eleanor Wang, James R. Zengel, Sarah R. Leist, Alexandra Schäfer, Varun Sathyan, Padraig Hawkins, Kenichi Okuda, Cyrus Tau et al. · 2022 · Nature Genetics
  79. CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi
    Louise Bendixen, Trine I. Jensen, Rasmus Otkjær Bak · 2023 · Molecular Therapy
  80. A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor
    Brook E. Heaton, Edward M. Kennedy, Rebekah E. Dumm, Alfred T. Harding, Matthew T. Sacco, David M Sachs, Nicholas S. Heaton · 2017 · Cell Reports
  81. Transgenic mice for in vivo epigenome editing with CRISPR-based systems
    Matthew P. Gemberling, Keith Siklenka, Erica Rodriguez, Katherine R. Tonn Eisinger, Alejandro Barrera, Fang Liu, Ariel Kantor, Liqing Li, Valentina Cigliola, Mariah F. Hazlett et al. · 2021 · Nature Methods
  82. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival
    Vasilena Gocheva, Alexandra Naba, Arjun J. Bhutkar, Talia Guardia, Kathryn M. Miller, Carman Man-Chung Li, Talya L. Dayton, Francisco J. Sánchez Rivera, Caroline Kim-Kiselak, Noor Jailkhani et al. · 2017 · Proceedings of the National Academy of Sciences
  83. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer
    Peng Zou, Yiqun Xia, Jiansong Ji, Weiqian Chen, Jin‐San Zhang, Xi Chen, Vinothkumar Rajamanickam, Gaozhi Chen, Zhe Wang, Lingfeng Chen et al. · 2016 · Cancer Letters
  84. Gene Regulatory Elements, Major Drivers of Human Disease
    Sumantra Chatterjee, Nadav Ahituv · 2017 · Annual Review of Genomics and Human Genetics
  85. The chemistry of Cas9 and its CRISPR colleagues
    Janice S. Chen, Jennifer A. Doudna · 2017 · Nature Reviews Chemistry
  86. CRISPR-UMI: single-cell lineage tracing of pooled CRISPR–Cas9 screens
    Georg Michlits, Maria Hubmann, Szu-Hsien Sam Wu, Gintautas Vainorius, Elena Budusan, Sergei Zhuk, Thomas Rainer Burkard, Maria Novatchkova, Martin Aichinger, YiQing Lü et al. · 2017 · Nature Methods
  87. Spatiotemporal Control of CRISPR/Cas9 Function in Cells and Zebrafish using Light‐Activated Guide RNA
    Wenyuan Zhou, Wes Brown, Anirban Bardhan, Michael Delaney, Amber S. Ilk, Randy R. Rauen, Shoeb I. Kahn, Michael Tsang, Alexander Deiters · 2020 · Angewandte Chemie International Edition
  88. CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma
    Siyuan John Liu, Martina Malatesta, Brian V. Lien, Parna Saha, Shivani S. Thombare, Sung Jun Hong, Leslie Pedraza, Mark Koontz, Kyounghee Seo, Max A. Horlbeck et al. · 2020 · Genome biology
  89. CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice
    Tetsushi Yamagata, Matthieu Raveau, Kenta Kobayashi, Hiroyuki Miyamoto, Tetsuya Tatsukawa, Ikuo Ogiwara, Shigeyoshi Itohara, Takao K. Hensch, Kazuhiro Yamakawa · 2020 · Neurobiology of Disease
  90. A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation
    Katherine E. Savell, Svitlana V. Bach, Morgan E. Zipperly, Jasmin S. Revanna, Nicholas A. Goska, Jennifer J. Tuscher, Corey G. Duke, Faraz A. Sultan, Julia N. Burke, Derek Williams et al. · 2019 · eNeuro
  91. Epigenetics and addiction
    Hamilton, Peter J, Nestler, Eric J · 2019 · Current Opinion in Neurobiology
  92. In Vivo Transcriptional Activation Using CRISPR/Cas9 in Drosophila
    Shuailiang Lin, Ben Ewen‐Campen, Xiaochun Ni, Benjamin E. Housden, Norbert Perrimon · 2015 · Genetics
  93. Synthetic gene circuits for the detection, elimination and prevention of disease
    Ferdinand Sedlmayer, Dominique Aubel, Martin Fussenegger · 2018 · Nature Biomedical Engineering
  94. Large-Scale Transgenic Drosophila Resource Collections for Loss- and Gain-of-Function Studies
    Jonathan D. Zirin, Yanhui Hu, Luping Liu, Donghui Yang‐Zhou, Ryan Colbeth, Dong Yan, Ben Ewen‐Campen, Rong Tao, Eric Vogt, Sara VanNest et al. · 2020 · Genetics
  95. Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma
    Jiaqiang Dong, Jiong Li, Yang Li, Zhikun Ma, Yongxin Yu, Cun‐Yu Wang · 2021 · Nature Communications
  96. LADL: light-activated dynamic looping for endogenous gene expression control
    Kim, Ji Hun, Rege, Mayuri, Valeri, Jacqueline, Dunagin, Margaret C., Metzger, Aryeh, Titus, Katelyn R., Gilgenast, Thomas G., Gong, Wanfeng, Beagan, Jonathan A., Raj, Arjun et al. · 2019 · Nature Methods
  97. RNAi/CRISPR Screens: from a Pool to a Valid Hit
    Anne M. Schuster, Hélène Erasimus, Sabrina Fritah, Petr V. Nazarov, Eric Van Dyck, Simone P. Niclou, Anna Golebiewska · 2018 · Trends in biotechnology
  98. In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy
    Gaia Colasante, Yichen Qiu, Luca Massimino, Claudia Di Berardino, Jonathan H. Cornford, Albert Snowball, Mikail Weston, Steffan P. Jones, Serena Gea Giannelli, Andreas Lieb et al. · 2020 · Brain
  99. A tunable orthogonal coiled-coil interaction toolbox for engineering mammalian cells
    Tina Lebar, Duško Lainšček, Estera Merljak, Jana Aupič, Roman Jerala · 2020 · Nature Chemical Biology
  100. An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysis
    Tomohiro Hino, Satoshi N. Omura, Ryoya Nakagawa, Tomoki Togashi, Satoru N. Takeda, Takafumi Hiramoto, Satoshi Tasaka, Hisato Hirano, Takeshi Tokuyama, Hideki Uosaki et al. · 2023 · Cell